News | Women's Health | July 01, 2015

How Breast Density Can Affect Cancer Screenings

Penn State Hershey utilizing MRI, whole-breast ultrasound to improve cancer detection compared to mammography alone

Penn State Hershey, breast density, fibroglandular density, Susann Schetter

July 1, 2015 - When it comes to breast cancer screening, the fibroglandular density of your breasts affects how well a mammogram can detect cancerous tissues. That's why Pennsylvania and 20 other states have adopted laws requiring radiologists to include information about breast density in every woman's mammogram report, according to Susann Schetter, DO, co-medical director of Penn State Hershey Breast Center. Schetter's comments were published in a recent edition of The Medical Minute, a weekly health news feature produced by Penn State Milton S. Hershey Medical Center.

Breast density is described by four categories – A, B, C, and D – according to the American College of Radiology. Women who have a breast density of C (heterogeneously dense) or D (extremely dense) may want to inquire about screening methods besides mammography for early detection.

Schetter said only about 10 percent of the population has extremely fatty (A category) breasts and only about 10 percent have extremely dense (D category) breasts. Most women fall somewhere in the middle.

But breast density is not the only factor in developing breast cancer, nor is it a certain predictor of risk. For instance, younger women tend to have denser breasts, yet it is older women – who typically have less dense breast tissue – who are more at a risk for developing cancer.

And while breast density is also affected by weight, Schetter said it is always better to have a lower body-mass index (BMI) and denser breasts than to have fatty breasts and be overweight or obese because obesity increases the risk for breast cancer as well as other health problems.

"There are other metabolic activities that are going on in breast tissue that contribute to its density, so it's not just glandular tissue," she said. "We think the risk is actually highest for post-menopausal women with high breast density."

About 10 years ago, the switch to digital mammography improved identification of cancer in dense breast tissue by 30 percent, but for some women, that is still not good enough.

A mammogram image shows areas of "˜darkness,' representing fatty tissue, as well as areas of "˜whiteness' that represent the tissue which is the functional part of the breast. "The more of that white that is present on the image, the more dense the breast," Schetter said.

The problem, she said, is that cancerous tissues also show up white on a mammogram, so for women with high breast density, "it's harder for the radiologist to detect cancer because it's like looking for a snowball in a snowstorm."

Schetter said medical professionals are studying other imaging methods to supplement mammography for those with high breast density so they can do a better job of detecting cancer at the earliest stages.

Women with the highest risk of breast cancer – with more than 20 percent lifetime risk – are eligible for magnetic resonance imaging (MRI), but most women do not fall into that category. Those who have a moderately increased risk may want to consider whole-breast ultrasound, a technology that is now available at Penn State Hershey.

"It's easier to tolerate than mammography and it helps us to see inside the dense breast tissue in a different way," Schetter said. "It's also nice because an ultrasound doesn't use radiation, yet it gives us an image from the skin to chest wall of the breast tissue so we can page through and look for abnormalities."

When used in combination with mammography, the new technology is able to detect an additional two or three cancers in every 1,000 women screened. The current compromise is the possibility for false positive tests that may require a "˜second look' to determine normal breast tissue.

"So far, it has great promise," Schetter said.

For more information: www.pennstatehershey.org

Related Content

Study Examines Characteristics of Mobile Mammography Patients
News | Mammography | October 18, 2017
Significant differences were found among women receiving mammography at a cancer center versus those visiting a mobile...
Machine Learning Identifies Breast Lesions Likely to Become Cancer
News | Artificial Intelligence | October 18, 2017
A machine learning tool can help identify which high-risk breast lesions are likely to become cancerous, according to a...
Volpara Solutions to Showcase VolparaEnterprise Live! at RSNA
News | Mammography | October 16, 2017
Volpara Solutions will introduce VolparaEnterprise Live!, a mammography quality control tool, at the 2016 Radiological...
TMIST Mammography Study Opens Enrollment
News | Mammography | October 16, 2017
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of...
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
Joint Venture Partnership Opening 16 New Breast Screening Sites in Texas
News | Breast Imaging | October 04, 2017
HCA Healthcare Gulf Coast Division and Solis Mammography have entered into a joint venture agreement to make breast...
International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or...
Kubtec Announces Expansion of 3-D Tomosynthesis Technology
News | Digital Radiography (DR) | October 04, 2017
October 4, 2017 — Kubtec announced at the annual conference of the American Association of Pathology Assistants (AAPA
The Siemens Acuson

The Siemens Acuson

Feature | Breast Imaging | October 04, 2017 | By Melinda Taschetta-Millane
According to a new Market Study Report,1 the automated breast ultrasound system (ABUS) market will see a 21 percent...
Overlay Init